Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | SVRA | XNCR | ||
| Company | Enliven Therapeutics Inc | Savara Inc | Xencor Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.43 | 6.44 | 18.40 | ||
| High | 21.86 | 6.57 | 18.69 | ||
| Low | 20.98 | 6.31 | 17.27 | ||
| Latest | 21.81 | 6.50 | 17.30 | ||
| Change | +0.41 | +0.13 | -0.84 | ||
| % Change | +1.92% | +2.04% | -4.63% | ||
| Volume | 523,200 | 4,016,500 | 552,800 | ||
| 20-Day Average Volume | 522,935 | 2,856,935 | 750,485 | ||
| Previous Close | 21.40 | 6.37 | 18.14 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 20.97 | 5.02 | 15.93 | ||
| 20-Day Raw Stochastic | 76.96% | 96.17% | 75.04% | ||
| 20-Day Relative Strength | 53.85 | 75.69 | 61.15 | ||
| Weighted Alpha | -5.25 | +120.47 | +10.71 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 8% Sell | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.97% since 11/28/25 | +3.34% since 11/28/25 | -0.12% since 11/28/25 | ||
| Low | 19.58 on 12/01/25 | 5.55 on 12/02/25 | 15.69 on 12/02/25 | ||
| High | 21.86 on 12/05/25 | 6.61 on 12/03/25 | 18.69 on 12/05/25 | ||
| 1-Month | |||||
| %Chg | +17.89% since 11/05/25 | +61.29% since 11/05/25 | +20.39% since 11/05/25 | ||
| Low | 16.80 on 11/07/25 | 3.86 on 11/07/25 | 13.12 on 11/07/25 | ||
| High | 23.31 on 11/20/25 | 6.61 on 12/03/25 | 18.69 on 12/05/25 | ||
| 3-Month | |||||
| %Chg | +8.24% since 09/05/25 | +74.73% since 09/05/25 | +102.34% since 09/05/25 | ||
| Low | 16.80 on 11/07/25 | 3.34 on 10/08/25 | 8.19 on 09/08/25 | ||
| High | 24.64 on 10/31/25 | 6.61 on 12/03/25 | 18.69 on 12/05/25 | ||
| 6-Month | |||||
| %Chg | +2.06% since 06/05/25 | +173.11% since 06/05/25 | +89.69% since 06/05/25 | ||
| Low | 16.80 on 11/07/25 | 1.98 on 07/01/25 | 6.92 on 08/11/25 | ||
| High | 24.64 on 10/31/25 | 6.61 on 12/03/25 | 18.69 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,294,358 | 1,322,542 | 1,235,393 | ||
| Shares Outstanding, K | 59,347 | 203,468 | 71,410 | ||
| Annual Sales | 0 | 0 | 110,490,000 | ||
| Annual Net Income | -89,020,000 | -95,880,000 | -232,620,000 | ||
| Last Quarter Sales | 0 | 0 | 21,000,000 | ||
| Last Quarter Net Income | -20,150,000 | -29,560,000 | -6,030,000 | ||
| 60-Month Beta | 0.35 | 0.23 | 0.96 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 11/12/25 | -0.14 on 11/12/25 | -0.08 on 11/05/25 | ||
| Latest Earnings Date | 11/12/25 | 11/11/25 | 11/05/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||